Ultreia Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 30

  • Exits
  • 32

Exits

Ultreia Capital General Information

Company Description

Ultreia Capital was venture capital firm that used to specialize in the life science sectors.

Business Details

Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • Schutzengasse 25
  • P.O. Box 1310
  • 8021 Zurich
  • Switzerland

Ultreia Capital Investments (30)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Affinium Pharmaceuticals 30-Aug-2013 Later Stage VC 000.00 Pharmaceuticals Out of Business
SomaLogic 16-Nov-2010 00000 00000 0000 Biotechnology Generating Revenue
diaDexus 08-Jun-2010 00000000000 00.00 Biotechnology Profitable
Zyomyx 29-Jan-2010 00000 00000 00000 Diagnostic Equipment Out of Business
ESBATech 07-Aug-2008 00000 00000 000.00 Biotechnology Generating Revenue
Paratek Pharmaceuticals 16-Apr-2008 00000 00000 000.00 Pharmaceuticals Generating Revenue/Not Profitable
Genedata 01-Mar-2007 00000 00000 Enterprise Systems (Healthcare) Generating Revenue
Light Chain Bioscience 30-Jun-2005 00000 00000 00.000 Biotechnology Generating Revenue
Conforma Therapeutics 01-Apr-2005 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 3
Predix Pharmaceuticals Holdings 25-Jan-2005 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 30 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ultreia Capital Exits (32)

Company Name Exit Date Exit Type Exit Size
Genedata 01-Aug-2021 Secondary Transaction - Private
Light Chain Bioscience 01-Jun-2021 000000000 00000000
Intarcia 01-Nov-2020 0000000000: 000000
LifeSpan BioSciences 31-Aug-2018 0000000000
Paratek Pharmaceuticals 30-Oct-2014 0000000 000000 0000
Zyomyx 01-Oct-2014 000 00 00000000
Affinium Pharmaceuticals 11-Feb-2014 000000000000000000
7TM Pharma 01-Apr-2012 00000000 000000 00
CEPTYR 31-Mar-2012 Bankruptcy: Liquidation
Anadys Pharmaceuticals 23-Nov-2011 Merger/Acquisition 00000
You’re viewing 10 of 32 exits. Get the full list »

Ultreia Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »